ORAL THERAPY
Designed around the body’s own immune regulation
ABOUT AVETA BIOMICS
Built to extend the reach
of immunotherapy.
Aveta Biomics is a clinical-stage biotechnology company developing oral immunotherapies designed to extend the reach of immunotherapy across immune-cold and immune-hot tumors.
WHAT AVETA DOES
Many oncology drugs are built around a target.
Aveta is built around the tumor ecosystem.
REPROGRAM THE TUMOR ENVIRONMENT
Counter immune suppression upstream of checkpoints
COORDINATED ANTITUMOR IMMUNE RESPONSE
Enable immune activity across cold and hot tumors
WHY THIS WORK MATTERS
The measure of progress is
what treatment allows people to keep.
Cancer such as Head and neck cancer can affect the most human parts of daily life. Speaking, eating, smiling and connecting with others. That human reality remains at the center of why we do this work and our treatment is intended to not only treat active cancer and increase the lifespan but also preserve these most basic human needs and improve patients' health span.
EXECUTIVE LEADERSHIP
BOARD OF DIRECTORS
THE BOARD OF ADVISORS
Science-led. Clinically focused. Built to execute.
TRANSLATIONAL SCIENCEGLOBAL CLINICAL DEVELOPMENTREGULATORY & MANUFACTURING READINESS
Writing the next chapter of immuno-oncology
We welcome conversations with those who share our ambition to extend the reach of immunotherapy.